Charlie Harper
BSc, MSc, DPhil
Trial Data Scientist
Charlie is a data scientist working in the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) at Oxford Population Health.
His work aims to develop new trial methods to streamline large-scale randomised trials that produce reliable answers, including the use of healthcare systems data to recruit and follow-up participants. He lectures on the University of Oxford's MSc in Clinical Trials and MSc in Global Health Science and Epidemiology.
Charlie completed his undergraduate degree in Economics at the University of East Anglia and MSc in Economics at Bristol University. He obtained his DPhil in Population Health from Oxford Population Health, where he showed that UK healthcare systems data can be used to reliably follow-up participants in large cardiovascular trials.
Recent publications
Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials
Journal article
Reith C. et al, (2026), Lancet, 407, 689 - 703
Joint associations of device-measured step count and sleep duration with incident major adverse cardiovascular events: prospective analysis of the UK Biobank
Journal article
Yun J. et al, (2026), Eclinicalmedicine, 92
Step Counts and Stepping Intensity Among U.S. Adults: National Health and Nutrition Examination Survey 2011–2014
Journal article
Shreves AH. et al, (2026), Medicine and Science in Sports and Exercise, 1 - 33
Daily steps are a predictor of, but perhaps not a risk factor for Parkinson’s disease: findings from the UK Biobank
Journal article
Acquah A. et al, (2025), Npj Parkinson S Disease, 11
Active Monitoring for AtriaL FIbrillation (AMALFI): Rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation
Journal article
Wijesurendra R. et al, (2025), American Heart Journal, 290, 310 - 324